Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2009 | FTC | $2,100,000 |
Alpharma, Inc. | Pfizer | price-fixing or anti-competitive practices | 2004 | FTC | $2,500,000 |
Perrigo Company | Perrigo | price-fixing or anti-competitive practices | 2004 | FTC | $3,750,000 |
Hoechst AG | Sanofi | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
Merck KgaA | Merck KGaA (EMD) | price-fixing or anti-competitive practices | 2000 | DOJ_ANTITRUST | $14,000,000 |
Mallinckrodt ARD Inc | Mallinckrodt | price-fixing or anti-competitive practices | 2017 | FTC | $100,000,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $22,500,000 |
Alpharma, Inc. | Pfizer | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
Amphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals | price-fixing or anti-competitive practices | 2015 | MA-AG | $325,000 |
Andrx Corporation | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $40,000,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $40,000,000 |
Aventis Pharmaceuticals, Inc. | Sanofi | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
Barr Pharmaceuticals | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $5,900,000 |
Bausch & Lomb | Bausch Health | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $17,500,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $55,000,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $100,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
CIBA Vision | Novartis | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $5,000,000 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $4,340,100 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2000 | CA-AG | $1,446,700 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Eisai | Eisai | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $7,634,700 |
Eisai Co. | Eisai | price-fixing or anti-competitive practices | 2000 | CA-AG | $2,544,900 |
Eisai Co. | Eisai | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Endo International plc | Endo International | price-fixing or anti-competitive practices | 2019 | MULTI-AG | $2,300,000 |
Geneva Pharmaceuticals | Novartis | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $70,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
Hoffman-LaRoche | Roche | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $142,494,000 |
Hoffman-LaRoche | Roche | price-fixing or anti-competitive practices | 2000 | CA-AG | $47,498,000 |
Hoffman-LaRoche | Roche | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $60,000,000 |
Mallinckrodt plc | Mallinckrodt | price-fixing or anti-competitive practices | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $100,000,000 |
Merck KGaA | Merck KGaA (EMD) | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
Mylan Laboratories et al. | Viatris | price-fixing or anti-competitive practices | 2000 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
Organon USA Inc | Organon & Co. | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $36,000,000 |
Perrigo Company | Perrigo | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
Ranbaxy Pharmaceuticals, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
Schering-Plough Corporation | Merck | price-fixing or anti-competitive practices | 2009 | CA-AG | $21,300,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $17,551,650 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | CA-AG | $5,850,550 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2019 | CA-AG | $69,000,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
UCB Pharma, Inc. | UCB | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
Warner Chilcott Holdings | AbbVie | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $5,500,000 |
Sandoz Inc. | Sandoz Group | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $195,000,000 |
Apotex Corp. | Apotex Corp. | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $24,100,000 |
Indivior, Inc. | Indivior PLC | price-fixing or anti-competitive practices | 2020 | FTC | $10,000,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $52,000,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $65,700,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $10,000,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $250,000,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $72,500,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,100,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $19,900,000 |
Actavis Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $71,000,000 |
Actavis Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $41,000,000 |
Actavis Mid-Atlantic LLC | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $118,614,000 |
Allergan | AbbVie | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $934,903 |
Allergan | AbbVie | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $1,003,634 |
Allergan | AbbVie | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $806,991 |
Allergan | AbbVie | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $15,000,000 |
Allergan Inc. | AbbVie | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $3,000,000 |
Allergan Inc. | AbbVie | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $51,250,000 |
Allergan Inc. | AbbVie | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $30,000,000 |
Allergan PLC | AbbVie | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $62,500,000 |
Allergan PLC | AbbVie | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $120,000,000 |
Allergan, Inc. | AbbVie | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $13,450,000 |
American BioScience Inc. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $815,000 |
Amgen Inc. | Amgen | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $400,000 |
Andrx Corporation | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $55,000,000 |
Astellas Pharma US, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $98,000,000 |
Astellas Pharma US, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $13,250,000 |
AstraZeneca | AstraZeneca | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $24,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $20,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $13,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $90,000,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $800,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $3,500,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Barr Laboratories Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2017 | private lawsuit-state | $225,000,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $13,000,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $2,100,000 |
Bausch & Lomb Inc. | Bausch Health | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $10,000,000 |
Bausch Health Companies Inc. | Bausch Health | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $300,000,000 |
Boehringer Ingelheim Pharma GmbH | Boehringer Ingelheim | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $27,000,000 |
Boehringer Ingelheim Pharma GmbH | Boehringer Ingelheim | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $50,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $65,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,800,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,000,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $19,000,000 |